Contact Us

marketing@medicilon.com

ABOUT

Company Profile

Corporate Culture

Management Team

Company History

Message from the CEO

Honors and Awards

SERVICES

SERVICES

01 Drug Discovery

Chemistry Research Biology Research Early Pharmacokinetics

02 Pharmaceutical Research

Intermediates Active Pharmaceutical Ingredients Pharmaceutical preparation Analytical Method Development and Quality Control CMC Filings Analytical Testing Center

03 Preclinical Research

Pharmacology & Pharmacodynamics Drug Safety Evaluation DMPK Bioanalysis IND Filings

PLATFORM

PLATFORM

01 One-stop Integrated Services

Liposome Drug Development Drug Discovery Pharmaceutical Research Preclinical Research Botanical Drug Preclinical R&D

02 Innovative Drug R&D Services

Peptide Drug Conjugate (PDC) Antibody Nucleic Acid Drug Cellular Immunotherapies mRNA Vaccine PROTAC ADC

03 Key Technical Services for Drug R&D

Cytokine and Biomarker Detection Metabolite Identification (MetID) Drug Forming Research Flow Cytometry Technology SEND Format Conversion Flow Sorting NanoString nCounter Detection Routes of Drug Administration

04 Drug Efficacy Evaluation for Common Diseases

Rodent Cerebrovascular Disease Inflammatory and Immune Diseases IO Pharmacodynamic Model

05 High-end Preparations Technology Platform

Skin Topical Preparation Ophthalmic drug Inhalation drug

06 Targeted Drugs R&D Services

STAT3-targeted Drugs R&D Service KRAS-targeted Drugs R&D Service GLP-1 New Drug R&D Service

07 Safety Assessment Lab of Process Chemistry

08 Public Services

CAREERS

Talent Development

Campus Recruitment

Recruitment

NEWS

Medicilon Events

Featured Stories

Market Events

Videos

A.C.E.

INVESTORS

Stock Information

Investment Contact

CLIENT CENTER

Intellectual Property Protection

Clients Testimonials

Downloads

Partnerships

Medicilon Support

Newsletters

CN

中

Medicilon's Videos

News and Events

Medicilon Events Featured Stories Market Events Videos A.C.E.

Videos

Introduction of GLP-1s

Introduction of GLP-1s

2022 Medicilon's Annual Report Overview

2022 Medicilon's Annual Report Overview

Medicilon Platform Technologies to Enable Novel Drug Discovery

Medicilon Platform Technologies to Enable Novel Drug Discovery

Empowering global drug discovery and development : Medicilon's International Discovery Service Unit(IDSU)

Empowering global drug discovery and development : Medicilon's International Discovery Service Unit(IDSU)

A.C.E.-Patent enforcement and clearance for freedom-to-operate in the U.S.

A.C.E.-Patent enforcement and clearance for freedom-to-operate in the U.S.

A.C.E.| Seminar 1：Building a strong patent portfolio to gain market competitive advantages

A.C.E.| Seminar 1：Building a strong patent portfolio to gain market competitive advantages

What happened when AUC suddenly dropped in the repeated adminitration PKTK test

What happened when AUC suddenly dropped in the repeated adminitration PKTK test

How do we determine the low dose in reproductive toxicity tests?

How do we determine the low dose in reproductive toxicity tests?

Medicilon's Drug Discovery services: Chemical and Biological Services

Medicilon's Drug Discovery services: Chemical and Biological Services

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(781)535-1428(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy

-->